+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Deslanoside Market by Formulation (Injectable, Oral), Product Type (Brand, Generic), End User, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Deslanoside Market by Formulation (Injectable, Oral), Product Type (Brand, Generic), End User, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Sale

Deslanoside Market by Formulation (Injectable, Oral), Product Type (Brand, Generic), End User, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083212
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Deslanoside market is advancing steadily as healthcare organizations, pharmaceutical manufacturers, and technology partners prioritize innovation and supply resilience in cardiac therapeutics. This report delivers actionable intelligence designed for decision-makers responsible for growth strategies, procurement, and portfolio management within the evolving pharmaceutical sector.

Market Snapshot: Deslanoside Market Size and Growth Trends

The Deslanoside market grew from USD 99.56 billion in 2024 to USD 105.54 billion in 2025 and is projected to reach USD 140.43 billion by 2030 at a CAGR of 5.90%. Demand for Deslanoside is shaped by evolving treatment protocols and precision dosing innovations. Industry participants face escalating complexity from regulatory, supply chain, and tariff-based pressures, while digital integration in pharmaceutical workflows continues to redefine competitive positioning.

Scope & Segmentation

Gain deep insights across the full spectrum of the Deslanoside market, highlighting operational dynamics, product innovation, and end-use preferences. The study comprehensively analyzes adoption drivers, barriers, and growth opportunities by covering key segmentation criteria:

  • Formulation: Injectable (IM Injection, IV Injection), Oral
  • Product Type: Brand, Generic
  • End User: Ambulatory Centers, Clinics, Hospitals
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Application: Atrial Fibrillation, Congestive Heart Failure, Supraventricular Tachycardia
  • Geographic Coverage: Americas (including US states and major Latin American economies), Europe, Middle East & Africa (including leading European and emerging regional markets), and Asia-Pacific (spanning established and fast-emerging health economies)
  • Company Coverage: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Lonza Group AG, Thermo Fisher Scientific Inc., Cambrex Corporation, Recipharm AB

Key Takeaways for Senior Decision-Makers

  • Deslanoside remains critical in managing complex cardiac conditions, with its value rising amid precision dosing and innovative delivery platforms.
  • Digital health adoption—including wearable-enabled monitoring and real-time pharmacovigilance—enhances safety profiles and supports adaptive clinical strategies.
  • Collaborative partnerships between pharmaceutical firms and technology providers deliver remote-adjustable Deslanoside administration and drive integration of digital solutions into therapeutic care.
  • Manufacturers are strengthening supply chain resilience by expanding local production, diversifying suppliers, and pursuing strategic hedging to offset trade disruption.
  • Segmentation reveals clear trends: injectable forms dominate acute care settings, while oral trails advance outpatient management. Generics continue to gain share in cost-sensitive regions.
  • Regional market adoption varies, with regulatory rigor influencing brand strength in the EMEA region and rapid expansion in Asia-Pacific led by domestic manufacturing initiatives.

Tariff Impact: United States 2025 Adjustments

Tariff restructuring in the United States for 2025 has generated complex supply chain challenges for Deslanoside. Manufacturers are re-evaluating supplier relationships and are pursuing new partnerships to maintain cost stability and secure product flow. Healthcare institutions and distributors increasingly favor bulk procurement models and local production as pivotal methods to mitigate cost pressures, while regional manufacturing networks are growing to adapt to shifting trade landscapes.

Methodology & Data Sources

This report uses a mixed-methods approach, combining peer-reviewed literature, regulatory filings, and in-depth interviews with industry and clinical stakeholders. Data triangulation and cross-validation processes ensure reliability, while scenario planning models and external expert reviews reinforce key conclusions.

Deslanoside Market: Why This Report Matters

  • Enables strategic planning by clarifying market drivers, competitive risks, and opportunities across every key segment and geography.
  • Empowers executive decision-making with clear, validated insights on regulatory, technological, and supply chain shifts shaping the Deslanoside market.
  • Provides actionable recommendations to accelerate portfolio innovation, secure procurement routes, and enhance collaboration between clinical and digital teams.

Conclusion

Stakeholders navigating the Deslanoside market should emphasize operational agility, partnership cultivation, and investment in advanced formulations. This report serves as an essential guide to support strategic growth and operational resilience in a rapidly shifting therapeutic landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of biosimilar competition on pricing pressure in the deslanoside market in North America
5.2. Adoption trends of deslanoside intravenous formulations in critical care settings across Europe
5.3. Strategic partnerships between generic drugmakers and hospital networks to expand deslanoside distribution in emerging markets
5.4. Influence of revised heart failure treatment guidelines on demand for deslanoside compared to alternative cardiac glycosides
5.5. Assessment of manufacturing capacity expansions by key players to address global deslanoside supply chain constraints
5.6. Technological advancements in intravenous infusion devices enhancing deslanoside administration safety profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Deslanoside Market, by Formulation
8.1. Introduction
8.2. Injectable
8.2.1. IM Injection
8.2.2. IV Injection
8.3. Oral
9. Deslanoside Market, by Product Type
9.1. Introduction
9.2. Brand
9.3. Generic
10. Deslanoside Market, by End User
10.1. Introduction
10.2. Ambulatory Centers
10.3. Clinics
10.4. Hospitals
11. Deslanoside Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Deslanoside Market, by Application
12.1. Introduction
12.2. Atrial Fibrillation
12.3. Congestive Heart Failure
12.4. Supraventricular Tachycardia
13. Americas Deslanoside Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Deslanoside Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Deslanoside Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Dr. Reddy's Laboratories Ltd.
16.3.4. Aurobindo Pharma Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Cipla Limited
16.3.7. Lonza Group AG
16.3.8. Thermo Fisher Scientific Inc.
16.3.9. Cambrex Corporation
16.3.10. Recipharm AB
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DESLANOSIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DESLANOSIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DESLANOSIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DESLANOSIDE MARKET: RESEARCHAI
FIGURE 26. DESLANOSIDE MARKET: RESEARCHSTATISTICS
FIGURE 27. DESLANOSIDE MARKET: RESEARCHCONTACTS
FIGURE 28. DESLANOSIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DESLANOSIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DESLANOSIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY IM INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DESLANOSIDE MARKET SIZE, BY IM INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DESLANOSIDE MARKET SIZE, BY IV INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DESLANOSIDE MARKET SIZE, BY IV INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DESLANOSIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DESLANOSIDE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DESLANOSIDE MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DESLANOSIDE MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DESLANOSIDE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DESLANOSIDE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DESLANOSIDE MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DESLANOSIDE MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DESLANOSIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DESLANOSIDE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DESLANOSIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DESLANOSIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DESLANOSIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DESLANOSIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DESLANOSIDE MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DESLANOSIDE MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DESLANOSIDE MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DESLANOSIDE MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DESLANOSIDE MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DESLANOSIDE MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 82. CANADA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 83. CANADA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. CANADA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. CANADA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. CANADA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. CANADA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. CANADA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. MEXICO DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. MEXICO DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. MEXICO DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. MEXICO DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. GERMANY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 156. GERMANY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 157. GERMANY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. GERMANY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. GERMANY DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. GERMANY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. GERMANY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. GERMANY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. FRANCE DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. FRANCE DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. FRANCE DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 168. FRANCE DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 169. FRANCE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. FRANCE DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. FRANCE DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. FRANCE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. FRANCE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. FRANCE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. ITALY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. ITALY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. ITALY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 192. ITALY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 193. ITALY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ITALY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ITALY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ITALY DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ITALY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ITALY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. ITALY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SPAIN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. SPAIN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. SPAIN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 204. SPAIN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 205. SPAIN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. SPAIN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SPAIN DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SPAIN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SPAIN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. SPAIN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. DENMARK DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. DENMARK DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. DENMARK DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 252. DENMARK DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 253. DENMARK DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. DENMARK DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. DENMARK DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. DENMARK DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. DENMARK DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. DENMARK DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. QATAR DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. QATAR DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. QATAR DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 276. QATAR DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 277. QATAR DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. QATAR DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. QATAR DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. QATAR DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. QATAR DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. QATAR DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. FINLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. FINLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. FINLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 288. FINLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 289. FINLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. FINLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FINLAND DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FINLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. FINLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. FINLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. EGYPT DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. EGYPT DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. EGYPT DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 324. EGYPT DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 325. EGYPT DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. EGYPT DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. EGYPT DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EGYPT DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. EGYPT DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. EGYPT DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. EGYPT DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. TURKEY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. TURKEY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. TURKEY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 336. TURKEY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 337. TURKEY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. TURKEY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. TURKEY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. TURKEY DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. TURKEY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. TURKEY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. TURKEY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. TURKEY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. ISRAEL DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. ISRAEL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. ISRAEL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. NORWAY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 358. NORWAY DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 359. NORWAY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 360. NORWAY DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 361. NORWAY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 362. NORWAY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 363. NORWAY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 364. NORWAY DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 365. NORWAY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. NORWAY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. NORWAY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 368. NORWAY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 369. POLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 370. POLAND DESLANOSIDE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 371. POLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 372. POLAND DESLANOSIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 373. POLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 374. POLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 375. POLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 376. POLAND DESLANOSIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 377. POLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 378. POLAND DESLANOSIDE MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Deslanoside market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Cambrex Corporation
  • Recipharm AB

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 105.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 140.43 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Deslanoside Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Deslanoside Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Deslanoside (CAS 17598-65-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Deslanoside (CAS 17598-65-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Colchicine Market by Indication (Behçet's Disease, Familial Mediterranean Fever, Gout), Formulation (Injectable, Oral Capsule, Oral Tablet), Route, End User, Distribution Channel, Dosage - Global Forecast 2025-2030 - Product Image

Colchicine Market by Indication (Behçet's Disease, Familial Mediterranean Fever, Gout), Formulation (Injectable, Oral Capsule, Oral Tablet), Route, End User, Distribution Channel, Dosage - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From

About the Deslanoside Market

Deslanoside is a cardiovascular drug used to treat congestive heart failure and other heart-related conditions. It is a type of cardiac glycoside, a class of drugs that work by increasing the force of contraction of the heart muscle. Deslanoside is used to treat a variety of heart conditions, including atrial fibrillation, ventricular tachycardia, and ventricular fibrillation. It is also used to treat high blood pressure and to reduce the risk of stroke. Deslanoside is available in both oral and injectable forms. Deslanoside is a widely used drug in the cardiovascular market, and is available in many countries around the world. It is generally well tolerated, with few side effects. However, it can interact with other medications, so it is important to discuss any potential interactions with a doctor before taking deslanoside. Some companies in the Deslanoside market include Sanofi, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.